DIABETIC CARDIOMYOPATHY. RESISTIN: A CONTROL OF A MYOCARDIAL HYPERTROPHY

DIABETIC CARDIOMYOPATHY. RESISTIN: A CONTROL OF A MYOCARDIAL HYPERTROPHY

Aim. To evaluate the association of serum resistin with morphological and functional indices of hypertrophic myocardium in patients with type 2 diabetes and chronic heart failure (CHF) with preserved left ventricular ejection fraction.Material and methods. Patients (n=60; 12 men and 48 women) with t...

Full description

Saved in:

Bibliographic Details
Main Authors:	An. A. Aleksandrov, O. A. Shatskaya, S. S. Kuharenko, M. N. Yadrihinskaya, E. N. Abdalkina, E. N. Drozdova, M. V. Shestakova
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	diabetic cardiomyopathy resistin left ventricular hypertrophy
Online Access:	https://www.rpcardio.online/jour/article/view/214
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ASSOCIATIONS BETWEEN CLINICAL COURSE, LEFT VENTRICULAR HYPERTROPHY SEVERITY AND ACE GENE I/D POLYMORPHISM IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND HYPERTENSIVE HEART
by: M. D. Smirnova, et al.
Published: (2009-04-01)

Transplantation of cardiac allografts with left ventricular hypertrophy 1.5 cm and more
by: V. N. Poptsov, et al.
Published: (2019-05-01)

PERIOPERATIVE PERIOD FOLLOWING HEART TRANSPLANTATION WITH SEVERE LEFT VENTRICULAR HYPERTROPHY
by: V. N. Poptsov, et al.
Published: (2012-05-01)

Comprehensive plasma metabolomics profiling develops diagnostic biomarkers of obstructive hypertrophic cardiomyopathy
by: Hao Cui, et al.
Published: (2025-04-01)

LEFT VENTRICULAR HYPERTROPHY IN PATIENTS ON CHRONIC HAEMODIALYSIS
by: A. G. Strokov, et al.
Published: (2010-06-01)

Identification of candidate cardiomyopathy modifier genes through genome sequencing and RNA profiling
by: Malene E. Lindholm, et al.
Published: (2025-07-01)

In search of heart barometer—advantage of left atrial dimension over electrocardiographic indices of left ventricular hypertrophy in arterial hypertension
by: Bogusława Nowak, et al.
Published: (2023-07-01)

The detection of left ventricular hypertrophy and diastolic dysfunction
by: G.R. Norton
Published: (2012-04-01)

Clinical manifestation and outcomes of children with hypertrophic cardiomyopathy in Kosovo
by: Ramush A Bejiqi, et al.
Published: (2020-04-01)

THE PREVALENCE OF ARTERIAL HYPERTENSION AND THE SPECIFIC FEATURES OF DEVELOPMENT OF LEFT VENTRICULAR HYPERTROPHY IN RADIATION-EXPOSED PERSONS
by: S. K. Kukushkin, et al.
Published: (2015-10-01)

Prevalence of myocarditis and its contribution to the course of primary myocardial hypertrophy
by: Yu. A. Lutokhina, et al.
Published: (2023-11-01)

The modern view on diabetic cardiomyopathy
by: P. Kh. Dzhanashiya, et al.
Published: (2010-04-01)

Multidisciplinary approach in the differential diagnosis of left ventricular hypertrophy: a case report
by: M. M. Kudryavtseva, et al.
Published: (2024-03-01)

Comparison of the association of brachial arterial pressure and parameters of central aortic pressure with left ventricular hypertrophy in the general population of Novosibirsk
by: E. E. Tsvetkova, et al.
Published: (2019-02-01)

Left ventricular hypertrophy: prognostic value, pathogenesis, possible remodeling: focusing on angiotensin receptor antagonists
by: M. D. Smirnova, et al.
Published: (2007-12-01)

Increased left ventricular mass as a marker of left ventricular hypertrophy in normotensive type 2 DM patients
by: Moustafa Kamal Eldin Ibrahim Khalil Saad, et al.
Published: (2025-03-01)

HYPERTHYROIDISM AND ATRIAL FIBRILLATION
by: I. M. Marusenko, et al.
Published: (2017-07-01)

The Role of Cardiac Magnetic Resonance Imaging in the Management of Hypertrophic Cardiomyopathy
by: Luca Pugliese, et al.
Published: (2025-05-01)

Influence of Echocardiographic Criteria on the Prevalence and Prognostic Implication of Left Ventricular Hypertrophy: A Nationwide Population‐Based Study
by: Anping Cai, et al.
Published: (2025-04-01)

Circadian blood pressure profile and myocardial hypertrophy in patients with renal arterial hypertension
by: E. Kh. Akhmetzyanova, et al.
Published: (2007-02-01)

Left ventricular hypertrophy in arterial hypertension and arrhythmia risk
by: I. G. Fomina, et al.
Published: (1970-01-01)

THE ROLE OF THE MATRIX METALLOPROTEINASES IN THE DEVELOPMENT OF LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME
by: A. N. Zakirova, et al.
Published: (2015-09-01)

Prospective Study of Modifiable Risk Factors of Arterial Hypertension and Left Ventricular Hypertrophy in Pediatric Patients on Hemodialysis
by: Dagmara Borzych-Dużałka, et al.
Published: (2024-06-01)

Relationship between parathyroid hormone and left ventricular hypertrophy in patients undergoing maintenance hemodialysis
by: WANG Li-rui, et al.
Published: (2016-01-01)

Comprehensive Review: Mavacamten and Aficamten in Hypertrophic Cardiomyopathy
by: Helin Savsin, et al.
Published: (2025-07-01)

ADIPOKINES CONTENT AND ECHOCARDIOGRAPHY INDICATORS OF WOMEN WITH HYPOTHYROIDISM
by: I. Yu. Kapralova, et al.
Published: (2015-01-01)

Myocardial fibrosis — a new component of heart remodeling in athletes?
by: A. S. Sharykin, et al.
Published: (2019-12-01)

An ECG-Based Model for Left Ventricular Hypertrophy Detection: A Machine Learning Approach
by: Marion Taconne, et al.
Published: (2025-01-01)

Diastolic and autonomous dysfunction linked to heterogeneous myocardial repolarization and arrhythmia risk in patients with arterial hypertension and left ventricular hypertrophy
by: A. P. Ivanov, et al.
Published: (2008-10-01)

How to escape from sudden death: a challenging case of a rare cardiomyopathy with an unexpected twist
by: Luísa Pinheiro, et al.
Published: (2025-06-01)

The role of cardiac MRI in risk stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy
by: M. S. Ishchenko, et al.
Published: (2024-05-01)

Predictive value of global longitudinal strain and geometry of left ventricle in patients with noncompaction cardiomyopathy
by: S. M. Komissarova, et al.
Published: (2021-12-01)

Desmoplakin and features of desmoplakin cardiomyopathy
by: R. P. Myasnikov, et al.
Published: (2023-11-01)

RISK FACTORS FOR THE DEVELOPMENT OF LEFT VENTRICULAR MYOCARDIAL HYPERTROPHY IN PATIENTS WITH GOUT
by: Evgenia Innokentyevna Markelova, et al.
Published: (2012-10-01)

Imidazoline receptor agonists and left ventricular hypertrophy
by: L. L. Kirichenko, et al.
Published: (2005-04-01)

Revisiting the transplantation of donor heart with left ventricular myocardial hypertrophy
by: M. A. Popov, et al.
Published: (2020-03-01)

Determinants of left atrial reservoir strain and diagnostic potential for cardiac amyloidosis in pathological left ventricular hypertrophy
by: Katsuji Inoue, et al.
Published: (2025-03-01)

Effects of left ventricular hypertrophy on prognosis of kidney in patients with chronic kidney disease of stages 3～4
by: XIAO Xiao-fen, et al.
Published: (2016-01-01)

THE SYNDROME OF LEFT VENTRICLE HYPERTROPHY
by: S. L. Dzemeshkevitch, et al.
Published: (2014-09-01)

EVALUATION OF LEPTIN SERUM LEVELS IN PATIENTS WITH METABOLIC SYNDROME AND LEFT VENTRICULAR MYOCARDIAL HYPERTROPHY
by: O. M. Drapkina, et al.
Published: (2018-03-01)